CytoMed Therapeutics Limited Ordinary Shares (GDTC) Stock Price

GDTCStock

$0.94−43.82%52W

Market Cap$11.06M

P/E—

PEG Ratio—

Div yield—

Beta0.02

GDTC Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-14.16%

Price vs S&P 500 (4W)7.43%

VGM Score63.96

Book Value / Share (Quarterly)$0.44

P/TBV (Annual)3.12x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.29

Price vs S&P 500 (YTD)-36.85%

EPS (TTM)$-0.27

10-Day Avg Trading Volume0.03M

EPS Excl Extra (TTM)$-0.27

EPS (Annual)$-0.27

ROI (Annual)-56.65%

Gross Margin (Annual)95.22%

Cash / Share (Quarterly)$0.14

Revenue Growth QoQ (YoY)142.45%

ROA (Last FY)-49.85%

Revenue Growth TTM (YoY)366.75%

EBITD / Share (TTM)$-0.24

ROE (5Y Avg)-147.06%

Cash Flow / Share (Annual)$-0.29

P/B Ratio1.96x

P/B Ratio (Quarterly)3.06x

Net Income / Employee (Annual)$-74,668

Net Interest Coverage (TTM)-16.12x

ROA (TTM)-48.71%

EPS Incl Extra (Annual)$-0.27

Current Ratio (Annual)5.17x

Quick Ratio (Quarterly)3.18x

3-Month Avg Trading Volume0.06M

52-Week Price Return-43.82%

Revenue / Employee (TTM)$6,065

Tangible BV / Share (Quarterly)$0.43

P/S Ratio (Annual)39.45x

Asset Turnover (Annual)0.04x

52-Week High$2.90

EPS Excl Extra (Annual)$-0.27

CapEx CAGR (5Y)21.10%

26-Week Price Return-2.91%

Quick Ratio (Annual)3.18x

13-Week Price Return-24.24%

Total Debt / Equity (Annual)0.07x

Current Ratio (Quarterly)5.17x

Enterprise Value$8.81M

Revenue / Employee (Annual)$6,065

Pretax Margin (Annual)-1231.96%

Cash / Share (Annual)$0.14

3-Month Return Std Dev83.72%

Net Income / Employee (TTM)$-74,668

ROE (Last FY)-60.82%

Net Interest Coverage (Annual)-16.12x

EPS Basic Excl Extra (Annual)$-0.27

Total Debt / Equity (Quarterly)0.07x

EPS Incl Extra (TTM)$-0.27

ROI (TTM)-54.29%

Revenue / Share (Annual)$0.02

Tangible BV / Share (Annual)$0.43

Price vs S&P 500 (52W)-62.13%

Year-to-Date Return-25.09%

5-Day Price Return6.43%

EPS Normalized (Annual)$-0.27

ROA (5Y Avg)-40.37%

Net Profit Margin (Annual)-1227.06%

Month-to-Date Return7.52%

Cash Flow / Share (TTM)$-0.20

EBITD / Share (Annual)$-0.24

Operating Margin (Annual)-1231.95%

LT Debt / Equity (Annual)0.06x

ROI (5Y Avg)-43.76%

LT Debt / Equity (Quarterly)0.06x

EPS Basic Excl Extra (TTM)$-0.27

P/TBV (Quarterly)3.12x

P/B Ratio (Annual)3.06x

Book Value / Share (Annual)$0.44

Price vs S&P 500 (13W)-27.04%

Beta0.02x

Revenue / Share (TTM)$0.02

ROE (TTM)-58.15%

52-Week Low$0.54

gGradeA

mGradeD

vgmGradeB

GDTC Analyst Recommendations

Apr 2025

May 2025

Jun 2025

Jul 2025

4.14

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
GDTCCytoMed Therapeutics Limited Ordinary Shares	—	A	D	$0.94
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About CytoMed Therapeutics Limited Ordinary Shares

CytoMed Therapeutics is a pre-clinical biopharmaceutical company developing cell-based immunotherapies for cancer treatment using proprietary technologies. The company operates two main segments: the development of innate immune and pluripotent stem cell therapies, and the processing and banking of cells, including cord blood-derived therapies. Based in Singapore and Malaysia, the company generates the majority of its revenue from Malaysia.